No Data
No Data
Wedbush Maintains Zentalis Pharmaceuticals(ZNTL.US) With Hold Rating, Maintains Target Price $4
Wedbush Remains a Hold on Zentalis Pharmaceuticals (ZNTL)
Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zentalis Gets FDA Fast-Track Designation for Azenosertib
Express News | Zentalis Pharmaceuticals: Azenosertib Fast Track Designation Granted for Cyclin E1 Positive Patients by FDA
Lexeo Therapeutics Appoints Kyle Rasbach as CFO
74537207 : thank you , your list helps a lot to narrow things down and do my own research, you are doing great work day after day!
nowuuuh : check out $8x8 (EGHT.US)$ too. earnings on the 4th
Jaguar8 OP nowuuuh : likely for Feb 4 ER
103851773 : Thanks Jag bro
HailTheApocalypse : thank you Mr. Jaguar
View more comments...